SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-011033
Filing Date
2012-02-27
Accepted
2012-02-27 14:00:05
Documents
4
Period of Report
2012-04-05
Effectiveness Date
2012-02-27

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v303248_def14a.htm DEF 14A 258100
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_talon.jpg GRAPHIC 14282
4 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-12-011033.txt   279575
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

IRS No.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32626 | Film No.: 12641189
SIC: 2834 Pharmaceutical Preparations